Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer

BACKGROUND: To evaluate whether urine laminin‐γ2 monomer (Ln‐γ2m) offers a useful biomarker for patients with non‐muscle‐invasive bladder cancer (NMIBC). METHODS: Participants comprised 297 patients, including 111 patients with NMIBC, 136 patients with benign genitourinary disease (BD) and 50 health...

Descripción completa

Detalles Bibliográficos
Autores principales: Karashima, Takashi, Umemoto, Susumu, Kishida, Takeshi, Osaka, Kimito, Nakagawa, Masatoshi, Yoshida, Eisaku, Yoshimura, Toru, Sakaguchi, Masahiko, Nishimoto, Hiroyuki, Tai, Mami, Inoue, Keiji, Seiki, Motoharu, Koshikawa, Naohiko, Shuin, Taro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939167/
https://www.ncbi.nlm.nih.gov/pubmed/35924681
http://dx.doi.org/10.1002/cam4.5087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939167/
https://www.ncbi.nlm.nih.gov/pubmed/35924681
http://dx.doi.org/10.1002/cam4.5087

Ejemplares similares